Curis (STU:CUS1) Cyclically Adjusted PS Ratio: (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CUS1 Curis Inc STU:CUS1
55 GF Score
Price €1.32
GF Value €8.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Curis Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Curis  (STU:CUS1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Curis Cyclically Adjusted PS Ratio Related Terms


Curis Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Curis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Cyclically Adjusted PS Ratio Chart

Curis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.27 1.30 1.94 0.57 0.21

Curis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.33 0.21 0.00 0.00

STU:CUS1 vs ASBP, VTGN, TOVX: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Curis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curis Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Curis's Cyclically Adjusted PS Ratio falls into.


STU:CUS1
55GF Score
Curis Inc STU:CUS1
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Curis's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Curis's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/333.9520*333.9520
=0.000

Current CPI (Jun. 2026) = 333.9520.

Curis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 23.742 241.428 32.841
201612 31.986 241.432 44.243
201703 28.056 243.801 38.430
201706 25.472 244.955 34.726
201709 28.096 246.819 38.015
201712 33.610 246.524 45.530
201803 24.120 249.554 32.277
201806 24.313 251.989 32.221
201809 29.398 252.439 38.891
201812 29.181 251.233 38.789
201903 18.843 254.202 24.755
201906 22.325 256.143 29.107
201909 31.241 256.759 40.633
201912 35.639 256.974 46.315
202003 28.512 258.115 36.889
202006 21.172 257.797 27.426
202009 17.118 260.280 21.963
202012 15.067 260.474 19.317
202103 8.031 264.877 10.125
202106 8.284 271.696 10.182
202109 11.279 274.310 13.731
202112 12.114 278.802 14.510
202203 8.157 287.504 9.475
202206 9.886 296.311 11.142
202209 12.192 296.808 13.718
202212 11.307 296.797 12.722
202303 8.864 301.836 9.807
202306 8.380 305.109 9.172
202309 9.283 307.789 10.072
202312 8.554 306.746 9.313
202403 6.640 312.332 7.100
202406 8.127 314.175 8.639
202409 8.892 315.301 9.418
202412 8.318 315.605 8.802
202503 5.179 319.799 5.408
202506 3.777 322.561 3.910
202509 3.452 324.800 3.549
202512 1.232 324.054 1.270
202603 0.000 330.213 0.000
202606 0.000 333.952 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Curis (STU:CUS1) Overvalued in 2026?

Based on GuruFocus' analysis, Curis stock appears to be undervalued. The current stock price of €1.32 is trading 83.7% below its estimated GF Value™ of €8.10. GuruFocus considers Curis to be Possible Value Trap.

Key valuation signals for STU:CUS1:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €8.10 vs. price of €1.32 (83.7% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the STU:CUS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Curis Business Description

Other Exchanges CRIS:USACUS0:Germany
Address 128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
55GF Score

Get the complete analysis for STU:CUS1

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.32
Price
€8.10
GF Value